GERMANY UP CLOSE: IVDs Industry Says Reg Changes Must Be Proportionate And Relevant
This article was originally published in Clinica
Germany’s IVDs industry is the largest in Europe, with a local market valued at €2.2bn (reagents and equipment/systems) in 2014-15. It accounts for 20% of the wider European market, but the overwhelmingly SMEs-based industry is nervous about the changes that the proposed EU IVDR will bring, clearly worried that an inappropriately heavy regulatory hand will damage the sector’s ability to innovate
You may also be interested in...
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.
EU medical device consultant Trevor Lewis takes note of the recent, if belated, progress towards the building of the post-MDR playing field for medical device companies in Europe, but calls political decision-makers and economic operators to account: getting it right is nothing short of a matter of life and death, he tells In Vivo.